All sites C00-96,D32-33,D42-43,D45-47,D76 926 88.6 3.9 3.1 0.8 3.6
Mouth, pharynx C00-14 13 98.5 - 1.5 - -
  Lip C00 3 100.0 - - - -
  Tongue C02 2 100.0 - - - -
  Mouth, other C03-06 5 100.0 - - - -
  Salivary glands C07-08 2 88.9 - 11.1 - -
  Pharynx C01,C09-14 2 100.0 - - - -
Digestive organs C15-26 164 77.1 6.6 9.1 1.3 5.9
  Oesophagus C15 3 93.3 - - 6.7 -
  Stomach C16 14 94.3 1.4 1.4 1.4 1.4
  Small intestine C17 4 95.0 - - - 5.0
  Colon C18 58 91.7 0.3 4.2 0.7 3.1
  Rectum, rectosigmoid C19-20 21 97.1 - 1.0 - 1.9
  Anus C21 2 100.0 - - - -
  Liver C22 12 75.9 5.2 12.1 - 6.9
  Gallbladder, bile ducts C23-24 11 51.8 23.2 14.3 1.8 8.9
  Pancreas C25 32 42.0 20.4 24.7 1.9 11.1
  Other digestive organs C26 7 42.9 8.6 17.1 8.6 22.9
Respiratory organs C30-39 61 62.2 20.7 7.6 2.6 6.9
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 1 100.0 - - - -
  Lung, trachea C33-34 58 60.8 21.6 7.6 2.7 7.2
  Mediastinum, pleura C38 0 50.0 - 50.0 - -
Bone C40-41 1 83.3 - - - 16.7
Melanoma of the skin C43 24 99.2 0.8 - - -
Skin, non-melanoma C44 46 100.0 - - - -
Mesothelioma C45 1 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 7 100.0 - - - -
Breast C50 279 98.8 0.5 0.3 0.1 0.3
Female genital organs C51-58 103 93.4 2.3 1.6 0.8 1.9
  Cervix uteri C53 11 96.5 1.8 - 1.8 -
  Corpus uteri C54 51 98.4 0.4 0.4 - 0.8
  Uterus, other C55,C58 1 25.0 25.0 - - 50.0
  Ovary C56 27 85.8 4.5 3.7 2.2 3.7
  Other female genital C51-52,C57 13 90.6 4.7 3.1 - 1.6
Urinary organs C64-68 43 93.1 1.4 3.2 - 2.3
  Kidney C64 28 92.1 2.1 3.6 - 2.1
  Bladder and urinary tract2 C65-68 15 94.8 - 2.6 - 2.6
Eye C69 1 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 37 84.0 - 7.0 - 9.1
Thyroid gland C73 41 97.6 2.4 - - -
Other endocrine glands C74-75 2 62.5 - 12.5 - 25.0
Illdefined or unknown C76,C80 18 54.4 16.7 7.8 8.9 12.2
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 84 81.8 4.5 1.2 0.9 11.6
  Hodgkin lymphoma C81 4 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 34 96.5 - - 0.6 2.9
  Malignant immunoproliferative diseases C88 1 66.7 - - - 33.3
  Myeloma and other plasma cell tumors C90 15 69.9 8.2 4.1 1.4 16.4
  Leukaemia C91-95 22 78.6 8.9 0.9 0.9 10.7
  Myelodysplastic syndromes D46 3 56.3 18.8 6.3 - 18.8
  Myeloproliferaitive neoplasms D45,D47 5 37.0 - - 3.7 59.3
Not included above
  Carcinoma in situ of the breast D05 29 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 99 100.0 - - - -
  Borderline tumour of the ovary D39 11 96.2 - - - 3.8
  Basal cell carcinoma of the skin 264 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.